RELEReleases

Glasswall Debuts Genesis to Secure Specialized File Formats

Glasswall has launched Genesis, a Zero Trust file protection platform engineered to sanitize documents across defense, intelligence, and healthcare sectors. By deconstructing files to their structural specifications and rebuilding them from scratch, the system eliminates hidden threats rather than relying on traditional detection methods that often miss sophisticated, evasive malware.

Bio & NewsAugust 18, 2026631 reads0

Traditional security tools operate on point-in-time judgments, attempting to determine if a file is malicious before granting access. Genesis replaces this reactive cycle with Content Disarm and Reconstruction (CDR). The software validates every file against its published format specification, discarding unauthorized content and generating a clean, policy-compliant version. This process ensures that only trusted data crosses organizational boundaries, providing security teams with a transparent audit trail of every modification made during the reconstruction.

The platform supports more than 140 file extensions, including specialized formats like DICOM for medical imaging and DWG for engineering. Unlike competitors that often flatten complex files into static PDFs, Genesis preserves the original fidelity and functionality of the source document. Built as a self-contained Native AOT application, the engine is designed to mitigate memory-corruption vulnerabilities, such as buffer overflows, while delivering processing speeds up to twice as fast as previous iterations.

Paul Farrington, Chief Product and Marketing Officer at Glasswall, noted that files remain a primary attack vector for organizations. By bringing Zero Trust principles inside the file itself, the company aims to move beyond signature-based detection. The software is compatible with Windows, Linux, and macOS across both Intel and Arm architectures, allowing for deployment in air-gapped environments, tactical edge locations, or cloud-based infrastructure.

Comments (0)

Leave a comment

No comments yet. Be the first!